Literature DB >> 29327719

The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.

Jan H von der Thüsen1, Elly Vandermeulen2, Robin Vos2, Birgit Weynand3, Erik K Verbeken3, Stijn E Verleden2.   

Abstract

Chronic lung allograft dysfunction continues to be the main contributor to poor long-term allograft survival after lung transplantation. The restrictive phenotype of chronic lung allograft dysfunction carries a particularly poor prognosis. Little is known about the pathogenetic mechanisms involved in restrictive chronic lung allograft dysfunction. In this study, we performed histomorphological and immunohistochemical analysis of restrictive chronic lung allograft dysfunction lungs. Explant lung tissue from 21 restrictive chronic lung allograft dysfunction patients was collected and histopathologic patterns of rejection, fibrosis and vascular changes were scored after routine histochemical stains and additional immunohistochemistry for endothelial markers and C4d. In all, 75% of cases showed evidence of acute cellular rejection; lymphocytic bronchiolitis was absent in most lungs, whereas in 55% there was obliterative bronchiolitis. Almost half of the cases showed a pattern consistent with pleuroparenchymal fibro-elastosis (n=10), and a subset showed nonspecific interstitial pneumonia (n=5) or irregular emphysema (n=5). Fibrinous alveolar exudates were frequently seen in association with fibrosis (n=6), but no diffuse alveolar damage was found. Evidence of microvascular damage was present in most cases. An emphysematous pattern of fibrosis was associated with a better survival (P=0.0030), whereas fibrinous exudates were associated with a worse survival (P=0.0007). In addition to the previously described nonspecific interstitial pneumonia and pleuroparenchymal fibro-elastosis patterns in restrictive chronic lung allograft dysfunction, we are the first to describe a pattern of fibrosis-induced subpleural/paraseptal emphysema. This pattern confers a better survival, whereas fibrinous exudates are associated with a worse survival. We believe that our findings offer a pathogenetic theory for pleuroparenchymal fibro-elastosis in restrictive chronic lung allograft dysfunction, and show that restrictive chronic lung allograft dysfunction is an increasingly heterogeneous disease with presumably different mechanisms of subpattern formation.

Entities:  

Mesh:

Year:  2018        PMID: 29327719     DOI: 10.1038/modpathol.2017.180

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure.

Authors:  Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Joseph W Rossano; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2015-09-03       Impact factor: 10.247

2.  Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation.

Authors:  Masaaki Sato; David M Hwang; Kaori Ohmori-Matsuda; Cecilia Chaparro; Thomas K Waddell; Lianne G Singer; Michael A Hutcheon; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2012-02-11       Impact factor: 10.247

3.  The site and nature of airway obstruction after lung transplantation.

Authors:  Stijn E Verleden; Dragoş M Vasilescu; Stijn Willems; David Ruttens; Robin Vos; Elly Vandermeulen; Jeroen Hostens; John E McDonough; Erik K Verbeken; Johny Verschakelen; Dirk E Van Raemdonck; Benoît Rondelet; Christiane Knoop; Marc Decramer; Joel Cooper; James C Hogg; Geert M Verleden; Bart M Vanaudenaerde
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

4.  Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure.

Authors:  Stijn E Verleden; Dragoş M Vasilescu; John E McDonough; David Ruttens; Robin Vos; Elly Vandermeulen; Hannelore Bellon; Rachel Geenens; Erik K Verbeken; Johny Verschakelen; Dirk E Van Raemdonck; Wim A Wuyts; Youri Sokolow; Christiane Knoop; Joel D Cooper; James C Hogg; Geert M Verleden; Bart M Vanaudenaerde
Journal:  Eur Respir J       Date:  2015-06-25       Impact factor: 16.671

5.  An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.

Authors:  Keith C Meyer; Ganesh Raghu; Geert M Verleden; Paul A Corris; Paul Aurora; Kevin C Wilson; Jan Brozek; Allan R Glanville
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

6.  Restrictive chronic lung allograft dysfunction: Where are we now?

Authors:  Stijn E Verleden; David Ruttens; Elly Vandermeulen; Hannelore Bellon; Dirk E Van Raemdonck; Lieven J Dupont; Bart M Vanaudenaerde; Geert Verleden; Robin Vos
Journal:  J Heart Lung Transplant       Date:  2014-11-11       Impact factor: 10.247

7.  CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.

Authors:  Michael Y Shino; S Samuel Weigt; Ning Li; Vyacheslav Palchevskiy; Ariss Derhovanessian; Rajan Saggar; David M Sayah; Aric L Gregson; Michael C Fishbein; Abbas Ardehali; David J Ross; Joseph P Lynch; Robert M Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

8.  Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.

Authors:  Stijn E Verleden; David Ruttens; Elly Vandermeulen; Hannelore Bellon; Adriana Dubbeldam; Walter De Wever; Lieven J Dupont; Dirk E Van Raemdonck; Bart M Vanaudenaerde; Geert M Verleden; Christian Benden; Robin Vos
Journal:  J Heart Lung Transplant       Date:  2016-04-16       Impact factor: 10.247

9.  Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics.

Authors:  Jan H von der Thüsen
Journal:  Curr Respir Med Rev       Date:  2013-08

10.  Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation.

Authors:  Danny Jonigk; Berenice Rath; Paul Borchert; Peter Braubach; Lavinia Maegel; Nicole Izykowski; Gregor Warnecke; Wiebke Sommer; Hans Kreipe; Robert Blach; Adrian Anklamm; Axel Haverich; Matthias Eder; Michael Stadler; Tobias Welte; Jens Gottlieb; Mark Kuehnel; Florian Laenger
Journal:  J Pathol Clin Res       Date:  2016-12-10
View more
  12 in total

1.  Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.

Authors:  Michael P Combs; Meng Xia; David S Wheeler; Elizabeth A Belloli; Natalie M Walker; Russell R Braeuer; Dennis M Lyu; Susan Murray; Vibha N Lama
Journal:  J Heart Lung Transplant       Date:  2020-04-19       Impact factor: 10.247

2.  Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation.

Authors:  Jamie L Todd; Fran L Kelly; Andrew Nagler; Kane Banner; Elizabeth N Pavlisko; John A Belperio; David Brass; S Sam Weigt; Scott M Palmer
Journal:  Am J Transplant       Date:  2019-12-01       Impact factor: 8.086

Review 3.  The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Hiroshi Ishii; Kazuki Nabeshima; Kentato Watanabe
Journal:  Histol Histopathol       Date:  2020-12-14       Impact factor: 2.303

Review 4.  Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).

Authors:  Anne-Laure Brun; Marie-Laure Chabi; Clément Picard; François Mellot; Philippe A Grenier
Journal:  Diagnostics (Basel)       Date:  2021-04-30

5.  Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.

Authors:  Keizo Misumi; David S Wheeler; Yoshiro Aoki; Michael P Combs; Russell R Braeuer; Ryuji Higashikubo; Wenjun Li; Daniel Kreisel; Ragini Vittal; Jeffrey Myers; Amir Lagstein; Natalie M Walker; Carol F Farver; Vibha N Lama
Journal:  JCI Insight       Date:  2020-12-03

6.  Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation.

Authors:  Arno Vanstapel; Stijn E Verleden; Eric K Verbeken; Peter Braubach; Tinne Goos; Laurens De Sadeleer; Janne Kaes; Bart M Vanaudenaerde; Danny Jonigk; Maximilian Ackermann; Laurens J Ceulemans; Dirk E Van Raemdonck; Arne P Neyrinck; Robin Vos; Geert M Verleden; Birgit Weynand
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

7.  Chronic lung allograft pathology lesions in two rat strain combinations.

Authors:  Federica Pezzuto; Francesca Lunardi; Marta Vadori; Davide Zampieri; Federica Casiraghi; Nadia Azzollini; Stefania Edith Vuljan; Marco Mammana; Luca Vedovelli; Marco Schiavon; Dario Gregori; Emanuele Cozzi; Federico Rea; Fiorella Calabrese
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

8.  Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis.

Authors:  David S Wheeler; Keizo Misumi; Natalie M Walker; Ragini Vittal; Michael P Combs; Yoshiro Aoki; Russell R Braeuer; Vibha N Lama
Journal:  Am J Transplant       Date:  2021-01-04       Impact factor: 9.369

Review 9.  Histopathology and genetic susceptibility in COVID-19 pneumonia.

Authors:  Jan von der Thüsen; Menno van der Eerden
Journal:  Eur J Clin Invest       Date:  2020-06-27       Impact factor: 5.722

10.  COMP: A Potential Early Biomarker of RAS After Lung Transplantation.

Authors:  Mirza Novo; Johan Westin; Lars-Magnus Andersson; Anton Jonsson Berdenius; Rickard Nordén; Jasper M Magnusson
Journal:  Transplant Direct       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.